121 - Stephen Ubl, President & CEO of PhRMA, on drug pricing, supply chains, and the industry’s miraculous Covid-19 response

Stephen Ubl is the president and CEO of the Pharmaceutical Research and Manufacturers of America, known as PhRMA, which represents America's leading biopharmaceutical research companies. 

The U.S. biopharmaceutical sector directly employs more than 800,000 Americans and invests more than $100 billion in research and development annually -- more than any other industry in America.  Steve leads the advocacy for this industry in Washington, DC and across the country. 

A policy expert with a record of enacting meaningful healthcare reform, Steve joins me today to do a deep dive on the drug industry – examining costs, the supply chain, and the industry’s unprecedented response to Covid-19.